What I do at MMV:

I provide support for CMC (chemistry, manufacturing, and controls) activities for various projects at early and late phases of drug development. I support the MMV portfolio with management of drug substance and drug product development in collaboration with internal teams and external partners. I ensure the availability of clinical supplies in line with project development plans.

Why I work at MMV:

Malaria is a preventable and curable disease. Despite the efforts from different organizations and many sections of industry & academia, the vast majority of malaria victims are children under five. In this fast-paced world, we can’t tackle malaria elimination at a slow pace. A disease-free life is a basic right of every childhood and malaria should not be an impediment. MMV provides a great opportunity to contribute for development of new antimalarial drugs including those appropriate for children, which will save and improve lives. 

More about me:

I bring about 12 years of experience in pharmaceutical development with expertise in paediatric dosage forms and new drug development. I have spent a decade in Novartis learning, unlearning, and relearning the various aspects of drug development form lab to launch. I hold a master’s degree in pharmaceutics from BITS (Birla Institute of Technology and Science), Pilani, India and master’s in business administration (MBA) from Osmania University in Hyderabad, India. In previous organizations, I have volunteered for the COVID-19 vaccine drive and to raise awareness of antimicrobial resistance.

Ask me about:

Apart from chemistry, manufacturing and controls, anything and everything about yoga, meditation and mindfulness. Also, the journey of life from medication to meditation.